Cyberonics Not Banking On Expanded VNS Therapy Coverage In 2006

Cyberonics projects no further coverage decisions in 2006 for its VNS Therapy for treatment-resistant depression (TRD) and has lowered its revenue projections accordingly

More from Archive

More from Medtech Insight